These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 9585205)
21. Immunization with HIV-1 SF162-derived Envelope gp140 proteins does not protect macaques from heterologous simian-human immunodeficiency virus SHIV89.6P infection. Xu R; Srivastava IK; Kuller L; Zarkikh I; Kraft Z; Fagrouch Z; Letvin NL; Heeney JL; Barnett SW; Stamatatos L Virology; 2006 Jun; 349(2):276-89. PubMed ID: 16527321 [TBL] [Abstract][Full Text] [Related]
22. Protective effects of nef-deleted SHIV or that having IFN-gamma against disease induced with a pathogenic virus early after vaccination. Enose Y; Kita M; Yamamoto T; Suzuki H; Miyake A; Horiuchi R; Ibuki K; Kaneyasu K; Kuwata T; Takahashi E; Sakai K; Shinohara K; Miura T; Hayami M Arch Virol; 2004 Sep; 149(9):1705-20. PubMed ID: 15593414 [TBL] [Abstract][Full Text] [Related]
24. AIDS vaccines show promise in primates. Clin Infect Dis; 2001 Oct; 33(7):i-ii. PubMed ID: 11592258 [No Abstract] [Full Text] [Related]
25. Induction of HIV-specific antibody response and protection against vaginal SHIV transmission by intranasal immunization with inactivated SHIV-capturing nanospheres in macaques. Miyake A; Akagi T; Enose Y; Ueno M; Kawamura M; Horiuchi R; Hiraishi K; Adachi M; Serizawa T; Narayan O; Akashi M; Baba M; Hayami M J Med Virol; 2004 Jul; 73(3):368-77. PubMed ID: 15170630 [TBL] [Abstract][Full Text] [Related]
26. Intravenous inoculation of replication-deficient recombinant vaccinia virus DIs expressing simian immunodeficiency virus gag controls highly pathogenic simian-human immunodeficiency virus in monkeys. Izumi Y; Ami Y; Matsuo K; Someya K; Sata T; Yamamoto N; Honda M J Virol; 2003 Dec; 77(24):13248-56. PubMed ID: 14645581 [TBL] [Abstract][Full Text] [Related]
27. Heterologous envelope immunogens contribute to AIDS vaccine protection in rhesus monkeys. Letvin NL; Huang Y; Chakrabarti BK; Xu L; Seaman MS; Beaudry K; Korioth-Schmitz B; Yu F; Rohne D; Martin KL; Miura A; Kong WP; Yang ZY; Gelman RS; Golubeva OG; Montefiori DC; Mascola JR; Nabel GJ J Virol; 2004 Jul; 78(14):7490-7. PubMed ID: 15220422 [TBL] [Abstract][Full Text] [Related]
28. Global dysfunction of CD4 T-lymphocyte cytokine expression in simian-human immunodeficiency virus/SIV-infected monkeys is prevented by vaccination. McKay PF; Barouch DH; Schmitz JE; Veazey RS; Gorgone DA; Lifton MA; Williams KC; Letvin NL J Virol; 2003 Apr; 77(8):4695-702. PubMed ID: 12663776 [TBL] [Abstract][Full Text] [Related]
29. Alternative interpretation of lymphocyte depletion studies using monoclonal antibodies in animals previously vaccinated with attenuated retroviral vaccines. Dittmer U; Hasenkrug KJ AIDS Res Hum Retroviruses; 1999 May; 15(8):785. PubMed ID: 10357475 [No Abstract] [Full Text] [Related]
30. Search for AIDS vaccine advances. Hum Vaccin Immunother; 2012 Feb; 8(2):151. PubMed ID: 22745942 [No Abstract] [Full Text] [Related]
31. A noninfectious simian/human immunodeficiency virus DNA vaccine that protects macaques against AIDS. Singh DK; Liu Z; Sheffer D; Mackay GA; Smith M; Dhillon S; Hegde R; Jia F; Adany I; Narayan O J Virol; 2005 Mar; 79(6):3419-28. PubMed ID: 15731236 [TBL] [Abstract][Full Text] [Related]
32. AIDS vaccine research. A new goal: preventing disease, not infection. Cohen J Science; 1993 Dec; 262(5141):1820-1. PubMed ID: 8266069 [No Abstract] [Full Text] [Related]
33. Chimeric adenovirus type 5/35 vector encoding SIV gag and HIV env genes affords protective immunity against the simian/human immunodeficiency virus in monkeys. Someya K; Xin KQ; Ami Y; Izumi Y; Mizuguchi H; Ohta S; Yamamoto N; Honda M; Okuda K Virology; 2007 Oct; 367(2):390-7. PubMed ID: 17628628 [TBL] [Abstract][Full Text] [Related]